Challenges to Cell Expansion for Allogenic Cell Therapies

被引:0
|
作者
Challener, Cynthia A.
机构
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:22 / 25
页数:4
相关论文
共 50 条
  • [1] Challenges for mesenchymal stromal cell therapies
    Martin, Ivan
    Galipeau, Jacques
    Kessler, Charles
    Le Blanc, Katarina
    Dazzi, Francesco
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (480)
  • [2] Challenges in the translation and commercialization of cell therapies
    Dodson, Brittany P.
    Levine, Aaron D.
    BMC BIOTECHNOLOGY, 2015, 15
  • [3] Challenges in the translation and commercialization of cell therapies
    Brittany P. Dodson
    Aaron D. Levine
    BMC Biotechnology, 15
  • [4] T-cell therapies for leukemia - Preventing recurrence after allogenic stem cell transplantation
    Roessig, C.
    Weber, G.
    Rettinger, E.
    MONATSSCHRIFT KINDERHEILKUNDE, 2010, 158 (03) : 232 - +
  • [5] Expansion processes for cell-based therapies
    Scibona, Ernesto
    Morbidelli, Massimo
    BIOTECHNOLOGY ADVANCES, 2019, 37 (08)
  • [6] Promises and challenges of engineered T cell therapies
    June, Carl
    HUMAN GENE THERAPY, 2009, 20 (11) : 1361 - 1361
  • [7] Addressing the challenges of bringing cell therapies to the patient
    MacNeil, S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 : S98 - S98
  • [8] Commercialization poses challenges for cell and gene therapies
    Mirasol, Feliza
    Pharmaceutical Technology, 2020, 2020 (03)
  • [9] Challenges and solutions to the sustainability of gene and cell therapies
    Scotti, Celeste
    Aiuti, Alessandro
    Naldini, Luigi
    NATURE REVIEWS GENETICS, 2025,
  • [10] Cell and Gene Therapies Face Manufacturing Challenges
    Challener, Cynthia A.
    BIOPHARM INTERNATIONAL, 2017, 30 (01) : 20 - +